BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30728464)

  • 21. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
    Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
    Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells.
    Lee W; Lee JH; Jun S; Lee JH; Bang D
    Sci Rep; 2018 Aug; 8(1):11879. PubMed ID: 30089886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
    Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA
    Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient viral delivery of Cas9 into human safe harbor.
    Hayashi H; Kubo Y; Izumida M; Matsuyama T
    Sci Rep; 2020 Dec; 10(1):21474. PubMed ID: 33293588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
    Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV
    Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multifunctional AAV-CRISPR-Cas9 and its host response.
    Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
    Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
    Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
    Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis.
    Ferri-Borgogno S; Barui S; McGee AM; Griffiths T; Singh PK; Piett CG; Ghosh B; Bhattacharyya S; Singhi A; Pradhan K; Verma A; Nagel Z; Maitra A; Gupta S
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32967217
    [No Abstract]   [Full Text] [Related]  

  • 29. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k "Helper" Proteins.
    Gwiazda KS; Grier AE; Sahni J; Burleigh SM; Martin U; Yang JG; Popp NA; Krutein MC; Khan IF; Jacoby K; Jensen MC; Rawlings DJ; Scharenberg AM
    Mol Ther; 2016 Sep; 24(9):1570-80. PubMed ID: 27203437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.
    Habbe N; Shi G; Meguid RA; Fendrich V; Esni F; Chen H; Feldmann G; Stoffers DA; Konieczny SF; Leach SD; Maitra A
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18913-8. PubMed ID: 19028870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
    Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
    Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras
    McAndrews KM; Xiao F; Chronopoulos A; LeBleu VS; Kugeratski FG; Kalluri R
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34282051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models.
    Saiki Y; Jiang C; Ohmuraya M; Furukawa T
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
    Yu W; Wu Z
    Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prime editor mouse to model a broad spectrum of somatic mutations in vivo.
    Ely ZA; Mathey-Andrews N; Naranjo S; Gould SI; Mercer KL; Newby GA; Cabana CM; Rideout WM; Jaramillo GC; Khirallah JM; Holland K; Randolph PB; Freed-Pastor WA; Davis JR; Kulstad Z; Westcott PMK; Lin L; Anzalone AV; Horton BL; Pattada NB; Shanahan SL; Ye Z; Spranger S; Xu Q; Sánchez-Rivera FJ; Liu DR; Jacks T
    Nat Biotechnol; 2024 Mar; 42(3):424-436. PubMed ID: 37169967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
    Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
    Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.